Lp(a) is a proven antigenic factor for ASCVD, proved by showing that high levels are causally linked to a higher risk of " ischemic stroke, aortic valve stenosis, and coronary artery disease [11]. Lp(a) engages in the thrombotic and lipid pooling processes responsible for ASCVD. Here, LPA is linked to atherosclerosis.